Hussain MS, Jakhmola V, Goyal K, Rekha A, Sultana A, Ali H, Gupta G. Targeting the NAD+/SIRT1 axis: A metabolic strategy to overcome oxaliplatin resistance in colorectal cancer. World J Gastroenterol 2025; 31(21): 106530 [PMID: 40538510 DOI: 10.3748/wjg.v31.i21.106530]
Please LOGIN to submit a new comment.